Resonance Health Stock

Resonance Health EBIT

The EBIT of Resonance Health (RHT.AX) as of Jul 16, 2026 is -1.84 M AUD. In the previous year, EBIT was -665,300.00 AUD — a change of 176.60% (lower).

EBIT

-1.84 MAUD

YoY

176.60%

Last updated:

In 2026, Resonance Health's EBIT was -1.84 M AUD, a 176.60% increase from the -665,300.00 AUD EBIT recorded in the previous year.

The Resonance Health EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (k AUD)
Date
EBIT (k AUD)
Jan 1, 2018
-246.30 base
Jan 1, 2019
904.30 base
Jan 1, 2020
-1,138.60 base
Jan 1, 2021
225.70 base
Jan 1, 2022
-1,769.10 base
Jan 1, 2023
-1,518.00 base
Jan 1, 2024
-665.30 base
Jan 1, 2025
-1,840.20 base
YEAREBIT (k AUD)
2025 -1,840.20
2024 -665.30
2023 -1,518.00
2022 -1,769.10
2021 225.70
2020 -1,138.60
2019 904.30
2018 -246.30
2017 -574.10
2016 -444.80
2015 120.50
2014 100.00
2013 -520.00
2012 -490.00
2011 -360.00
2010 -220.00
2009 570.00
2008 -220.00
2007 -670.00
2006 -3,500.00
Access this data via the Eulerpool API

Resonance Health Revenue

Resonance Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
2.91 M AUD
-246,300.00 AUD
224,600.00 AUD
Jan 1, 2019
3.66 M AUD
904,300.00 AUD
1.27 M AUD
Jan 1, 2020
3.71 M AUD
-1.14 M AUD
-715,100.00 AUD
Jan 1, 2021
3.82 M AUD
225,700.00 AUD
585,900.00 AUD
Jan 1, 2022
3.83 M AUD
-1.77 M AUD
-1.14 M AUD
Jan 1, 2023
4.51 M AUD
-1.52 M AUD
-780,400.00 AUD
Jan 1, 2024
8.80 M AUD
-665,300.00 AUD
169,300.00 AUD
Jan 1, 2025
11.16 M AUD
-1.84 M AUD
-1.73 M AUD

Resonance Health Margins

Resonance Health stock margins

The Resonance Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Resonance Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Resonance Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
0.00 %
-8.46 %
7.71 %
Jan 1, 2019
0.00 %
24.70 %
34.69 %
Jan 1, 2020
0.00 %
-30.69 %
-19.28 %
Jan 1, 2021
0.00 %
5.91 %
15.35 %
Jan 1, 2022
0.00 %
-46.17 %
-29.80 %
Jan 1, 2023
0.00 %
-33.65 %
-17.30 %
Jan 1, 2024
0.00 %
-7.56 %
1.92 %
Jan 1, 2025
0.00 %
-16.49 %
-15.53 %

Resonance Health Stock analysis

What does Resonance Health do? Resonance Health Ltd is an Australian company that operates in the medical technology industry. The company's business model is to offer groundbreaking solutions for the diagnosis and treatment of liver and iron diseases. As a pioneering company in the development of methods and technologies for quantifying liver and iron concentrations, Resonance Health continually sets new standards in the industry. The company was founded in 2000 by a team of biomedicine professionals from the University of Western Australia. Over the years, the company has gained a lot of experience and constantly evolved to keep up with the progress of medical technology. The goal is to provide patients with better treatment and improved quality of life. One division of the company is the development and manufacturing of diagnostic tools for quantifying liver and iron diseases such as hepatitis, fatty liver, or hemochromatosis. The quantification method used by Resonance Health is called FerriScan. This method is non-invasive and painless, using magnetic resonance imaging (MRI) to measure the concentration of iron in the tissue. This is particularly important as a change in iron content can indicate a progressing liver disease. In addition to the FerriScan diagnostic tool, Resonance Health also offers a software package for analyzing FerriScan results, which is used by physicians and clinicians to assess disease progression. Furthermore, the company also develops solutions in the field of hemochromatosis, a genetic disorder that can lead to increased iron levels in the body. Another division of Resonance Health is the provision of research and development services to further develop and improve FerriScan and other technologies. The company collaborates with other companies, scientific institutions, and universities to advance the current developments in liver and iron diagnostics. Resonance Health has a range of products that contribute to better diagnosis and treatment of liver and iron diseases. These include FerriScan, the FerriSmart software package for precise monitoring of iron and liver health, and Hepatica, a software supporting hospitals and clinics in the diagnosis of liver diseases. The company is an innovative leader in the industry, contributing to improving the quality of life for patients. The products and services of Resonance Health have helped doctors and clinicians to effectively treat and diagnose liver and iron diseases. Additionally, the company has established a strong scientific foundation and works closely with leading institutions to continuously develop innovative solutions. Resonance Health is a company with a rich history that continues to evolve to meet the demands of the medical technology industry. The company aims to continuously improve the diagnosis and treatment of liver and iron diseases and offer better solutions. Resonance Health is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Resonance Health's EBIT

Resonance Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Resonance Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Resonance Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Resonance Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Resonance Health stock

EBIT of Resonance Health is -1.84 M AUD in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Resonance Health

All Key Metrics — Resonance Health